SUBSCRIBE

Breaking News on Supplements & Nutrition - EuropeUS edition

Headlines > Industry

Loading...

How can firms make claim research successes their own, not their competitors’?

By Annie-Rose Harrison-Dunn+

06-Jun-2014
Last updated on 10-Jun-2014 at 20:37 GMT

Plant extracts may have different health benefits for certain compounds, meaning firms may be able to attain a health claim for their specific extracts only, says consultant Eric Chappuis.

Plant extracts may have different health benefits for certain compounds, meaning firms may be able to attain a health claim for their specific extracts only, says consultant Eric Chappuis.

Companies have to be clever about proprietary research, and plant extracts may hold unique opportunities in this respect, according to a food and nutrition industry consultant.

“Every time you make a specific [plant] extract, you can expect to have specific compound benefits and specific health benefits. The health claim regulation includes some things on data protection, which means how you can make your research your own success and not one of your competitors’,” Eric Chappius, director of consulting for Naturalpha, told NutraIngredients. 

“Plant extracts are very interesting in this framework as every plant extract may have a different health effect, then you are able to make a health claim application that may be usable only on your specific extract that you can protect through this specification,” he said.   

Talking with us on camera at this year’s Vitafoods in Geneva, Chappius said he also saw the discourse between food and nutrition and medical device status as a key area of movement in Europe. 

Minimum out, maximum in 

Speaking generally, he added that Barry Callebaut’s cocoa flavanol claim was a good example of companies being “smart” about maximizing competitive advantage with limited research input. 

“Basically when you’re investing money in research you want to be the only one to be authorised to use this specific research.” 

He said there were several options available to companies doing this. 

“Either firms can start from scratch, and the you can start something new but that’s quite a long-term strategy, otherwise you can also capitalise on what is existing. So you take less risk because you have money to invest but still you have to think very clearly about where you want to go and how you want to go there, how much time it will take you, how much money it will cost you and what the scientific risks are that it works or doesn’t work,” he said. 

“[Barry Callebaut] did it really in a smart way because what they did was they bought the last piece of the puzzle - because they had been capitalising on the data generated by one of their competitors – and they just bought a few studies that allowed them to protect that data in the framework of the health claim and they invested less money than if they had to do it from scratch,” he said.  

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Related products

Beauty chocolate: Astaxanthin in functional confectionery

Beauty chocolate: Algatechnologies touts red seaweed for functional confectionery

Efrat Kat

Director of marketing and sales, Algatechnologies

Keeping it clean: 3 botanical chiefs pull adulteration weeds

Keeping it clean: 3 botanical chiefs pull adulteration weeds

Antoine Bily, Naturex global R&D director

Christian Artaria, Indena marketing director, Holger Riemensperger, Frutarom general manager,...

Diet and cancer: Polyphenol trial data suggests significant clinical benefit for prostate cancer

Diet and cancer: Polyphenol trial data suggests significant clinical benefit for prostate cancer

Professor Robert Thomas

Consultant oncologist, Addenbrooke's and Bedford, Cambridge University Hospital

Are doctors seeing the preventative eye health potential of carotenoids?

Are doctors seeing the preventative eye health potential of carotenoids?

James Stringham

Research doctor, University of Georgia

Functional confectionery: What does the future hold?

Which big player will be first on functional confectionery scene?

Adrian Sagman

Vice president of international sales and marketing, Carmit Candy

Food science and technology conference wrap up

IFST conference paints ‘multi-coloured’ picture of food industry

The Institute of Food Science and Technology’s Jubilee conference offered something for everyone involved...

Grey zone around health claims in ‘commercial communication’

You talkin’ to me? The grey zone around health claims in ‘commercial communication’

Georgia Taylor

Marketing and claims advisor , Leatherhead

Dairy ingredients giant on Indonesia: ‘A lot of opportunities here’

Dairy ingredients giant on Indonesia: ‘A lot of opportunities here’

Jake Riddle

General manager, Kerry Asia Pacific

Indonesia stakes claim as SE Asia's most important food market

Indonesia stakes claim as SE Asia's most important food market

Indonesia's food industry will continue to grow in importance as its population of around...

NPD category busters: From ‘Teagurt’ to coffee fruit energy to Milo expansion

NPD category busters: From ‘Teagurt’ to coffee fruit energy to Milo expansion

Jane Barnett

Insights manager for Australia-New Zealand, south east Asia and India,...

HI-Japan show wrap: Ageing (& shrinking) population forces government-led nutrition rethink

HI-Japan show wrap: Ageing (& shrinking) population forces government-led nutrition rethink

Japan has always led the world in functional food experimentation even if the results...

Rise in demand for products with added proteins: expert

‘Weekend warriors’ drive added protein demand

Weekend fitness fanatics are driving the demand for more mainstream food and drink products,...

Saturated fat guidelines out, food guidelines in?

Get rid of nutrients and focus on foods in guidelines, says sat fat researcher

Benoit Lamarche

Saturated fat researcher, Laval University

UK researcher backs supplements for omega-3 intakes

UK researcher backs supplements for boosting omega-3 intakes

Philip Calder

Professor, University of Southamption

Saturated fats may not cause heart disease: Researcher

Saturated fats may not cause heart disease: Researcher

Prof. Philippe Legrand

Director of the biochemistry laboratory, Agrocampus Ouest

GM camelina matches fish oil omega-3 levels

The road to fish-oil equivalent GM camelina

Rothamsted Research has achieved omega-3 levels comparable to fish oil in its first GM...

Russian embargo impact on Arla whey and lactose interests 'minimal'

Russian embargo impact on Arla whey and lactose interests 'minimal': CEO

Henrik Andersen

Chief Executive Officer, Arla Foods Ingredients